Target intelligence / Profile preview

Immunoglobulin heavy variable 3-30-2 (IGHV3-30-2)

Target
IGHV3-30-2
Molecular classification
Immunoglobulin variable domain, Antibody variable region, Other (part of immunoglobulin gene family, not a classical target such as "enzyme" or "receptor")
01

Overview

Immunoglobulin heavy variable 3-30-2 (IGHV3-30-2) is a gene segment encoding one of the variable domains of the heavy chain in immunoglobulins (antibodies). The variable domain, generated through V(D)J recombination, combines with adjacent diversity (D) and joining (J) segments to form the antigen-binding site, allowing for a highly diverse antibody repertoire. IGHV3-30-2 is a member of a large family of variable gene segments at the immunoglobulin heavy-chain locus; homologs such as IGHV3-30 and IGHV3-33 exist with high sequence similarity[2]. Its product is not a standalone receptor or therapeutic drug target, but a genetic building block that allows B cells to generate a wide variety of antibodies, enabling the adaptive immune system to detect and neutralize diverse antigens[1][2][3]. Unlike canonical drug targets, IGHV3-30-2 has no direct small-molecule modulators or therapeutic interventions, although antibodies encoded using these segments may have importance in individual immune responses, such as during viral infection[2].

Other names
3-30.2PIGHV3302IGHV3-30-2
02

Biological functions

Antigen recognitionImmune response (humoral immunity)
03

Disease associations

Other (no direct association as a classical disease target; normal function in adaptive immunity)

Beyond the preview

Go deeper on Immunoglobulin heavy variable 3-30-2 (IGHV3-30-2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 3-30-2 (IGHV3-30-2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call